HIỆU QUẢ ĐIỀU TRỊ NHÂN TUYẾN GIÁP LÀNH TÍNH BẰNG SÓNG CAO TẦN TẠI BỆNH VIỆN NỘI TIẾT TRUNG ƯƠNG

Abstract

Ojectives: "Evaluate the effectiveness of Radiofrequency ablation (RFA) in treatment of benign thyroid nodules and "Identify complications following Radiofrequency Ablation of benign thyroid nodule for 3 months”. Method: A descriptive study with longitudinal follow-up was conducted on 55 patients diagnosed with benign thyroid nodules that being treated with RFA at Central Hospital of Endocrine from August 2023 to April 2024. Results: There was significant decrease of symptom score, cosmetic score, vascularity and thyroid nodule volume after 3 months of treatment. Symptom score 4.05 ± 0.86 decreased to 1.14 ± 0.98, cosmetic score 3.31 ± 0.72 decreased to 2.03 ± 0.19, vascularity 2.83 ± 0.79 reduced to 1.22 ± 0.42, thyroid nodule volume 6.43 ± 2.91 reduced to 3.08 ± 1.64. The decreases were significant with p<0.05. Before treatment, all of patients had symptom scores at morderate level; the cosmetic score was mainly ≥3 and the vascularity were mainly at grade II or higher. After 3 months of RFA, 3.64% patients had moderate symptom scores, 60% patients had mild symptom scores and 36.36% had no symptoms of thyroid nodules (the symptoms were completely gone); the cosmetic score decreased mainly to level 2 (96.36%); The mean volume reduction rate were mainly 60% or more (62.27%) and the vascularity of thyroid nodules decreased to only level I (78.18%) and level II (21.82%). Conclusion: RFA has been shown to be effective and safe in the treatment of benign thyroid nodules.